DJIA 18,024.06 183.54 1.03%
NASDAQ 5,005.39 63.97 1.29%
S&P 500 2,108.29 22.78 1.09%
market minute promo

Antares Pharma, Inc. (NASDAQ: ATRS)



company name or ticker

Cadence: What To Do With The Proceeds And A Post Mortem On A Successful Investment

Could Teva & Pfizer End Up In A Bidding War For Antares?

Sector Update: Healthcare Shares Mixed Pre-Market; Antares Pharma's OTREXUP Released

Sector Update: Healthcare

Antares Pharma Announces Availability of OTREXUP Injection for Subcutaneous Use to Treat Rheumatoid

Antares Pharma Announces Availability of OTREXUP Injection for Subcutaneous Use to Treat Rheumatoid Arthritis (RA) and Psoriasis in Adults, and Polyarticular Idiopathic Arthritis in Children

Is This the Top for Antares Pharma Inc (ATRS)? - Tale of the Tape

Antares Pharma (ATRS) Shares Cross Below 200 DMA

Antares' CEO Presents at Oppenheimer 24th Annual Healthcare Conference (Transcript)

3 Disruptive Medical Innovations You Can Invest In

3-D-printed organs, needle-free injectors, and inhalable insulin -- these three disruptive medical innovations that are being brought to the market respectively by Organovo, Antares Pharma, and MannKind.

Antares Pharma Awarded Additional U.S. Patent Protection for OTREXUP™

See More Articles...